Stay updated with breaking news from Miriam Cha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Photo: UCL website. Machine learning company, Rahko, has been bought by US-based biotechnology firm, Odyssey Therapeutics, in a move that will bring together artificial intelligence and drug-discovery software to improve medical development for patients with cancer and inflammatory diseases.
Machine learning company, Rahko, has been bought by US-based biotechnology firm, Odyssey Therapeutics, in a move that will bring together artificial
/PRNewswire/ -- Odyssey Therapeutics, a biotechnology company pioneering next generation precision immunomodulators and oncology medicines, today announced...
/PRNewswire/ -- Odyssey Therapeutics, a biotechnology company pioneering next generation precision immunomodulators and oncology medicines, today announced...
17 February 2021 AI startup founders reveal their artificial intelligence trends for 2021 From AI's increased use in healthcare, finance and HR to the challenge of talent acquisition and the growing importance of structured and unstructured data, 16 AI startup founders reveal their artificial intelligence trends for 2021 What are the big industry trends in the AI space? In the final article of a three part series* focusing on what AI startup founders are doing to navigate the fast growth AI industry, Information Age spoke to 16 founders of som...